Understanding and addressing diversity barriers ensure that digital therapeutics (DTx) are inclusive and effective for everyone, regardless of background or circumstances. This is important for two reasons: First, DTx can potentially improve health outcomes for diverse populations, including racial and ethnic minorities, people with disabilities, and those living in underserved communities. However, these populations often face barriers to accessing and using DTx, such as limited internet access or low health literacy. Second, the lack of diversity in developing and evaluating DTx can result in biased or incomplete research findings, which may limit their generalizability and impact. Therefore, investigating diversity in DTx can help identify gaps and areas for improvement, promote equity and inclusivity in healthcare, and ultimately lead to more effective and accessible digital health solutions for diverse populations.

In the frame of this Master’s thesis, you review existing DTx and assess how diversity is addressed in their design, implementation, and evaluation. The thesis could include the following components: 1) defining diversity in the context of DTx, 2) developing a framework for assessing diversity in DTx, 3) applying the framework to existing DTx and recommending approaches for improvement, 4) identifying barriers to diversity in DTx.